Sanofi And Regeneron Move Forward On ...

Sanofi And Regeneron Move Forward On Cholesterol Drug, But Face Competition

There are 1 comment on the Seeking Alpha story from Aug 16, 2012, titled Sanofi And Regeneron Move Forward On Cholesterol Drug, But Face Competition. In it, Seeking Alpha reports that:

In the cholesterol industry, there is great demand for alternatives to the statins that are currently available.

Join the discussion below, or Read more at Seeking Alpha.


West Chicago, IL

#1 Aug 31, 2012
Some drugs may have side effects when taken with other drugs. They might produce chemical reactions with harmful consequences. A drug called Fosamax which belongs to the biphosphonates class of drugs. There are quite a few lawsuits filed against its manufacturer because of its side effects experienced by patients using it. See it more here: .

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Despite $19 million salary, Mylan CEO failed to... (Sep '16) Mar 13 Seniors For Fairness 4
News Regeneron Pharmaceuticals Inc (REGN) Given Aver... Mar 12 Ralph Petrillo 1
News Bashful? Buy the little blue pill online (May '13) Mar 4 Josel 15
News Sanofi : FDA to review Dupixent (dupilumab) as ... Mar 2 Ralph Petrillo 1
News Merck beats 1Q profit views with tight cost con... (May '16) Feb 24 American People W... 3
News Berkshire buys Teva, feels IBM blues as Apple b... Feb '18 follow the money 1
News Tiny Colorado County sues giant opioid makers f... Jan '18 marta 1